PATENT CLAIM ANALYSIS

Application Number: 15907858
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-10
Patent Classification: ["514", "233200"]

Abstract:
The present disclosure relates to compounds that are Syk inhibitors and to their use in the treatment of various disease states, including cancer and inflammatory conditions. In particular embodiments, the structure of the compounds is given by Formula I: wherein R 1 , R 2 , R 3 , and R 4  are as described herein. The present disclosure further provides pharmaceutical compositions that include a compound of Formula I, or pharmaceutically acceptable salts thereof, and methods of using these compounds and compositions to treat conditions mediated by Syk. In certain embodiments, also disclosed are methods for treating a cancer in a subject (e.g., a human) in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof, in combination with a vinca-alkaloid, or a pharmaceutically acceptable salt thereof.

Claim (Index 35):
The method of  claim 34 , wherein the vinca-alkaloid is vindesine.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 88.0
- Lexical Diversity: 1.90361
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14795123', '15298950', '14796795', '15017394', '15622737']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7903690536406667
- 35 USC 102 Novelty (BERT): 0.5954963504635996
- Combined Prediction Score: 0.77088178332296
- Mean Citation Score: 440.436834
- Max Citation Score: 550.6877
- Similarity Product: 410.2587941830515

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test